Bristol Myers Squibb (BMS) has announced that its Opdivo (nivolumab) perioperative treatment regimen has been recommended by the European Medicines Agency’s human medicines committee for adults with ...
BeiGene’s Tevimbra (tislelizumab) has been recommended by the European Medicines Agency’s human medicines committee as part of a first-line combination treatment for an aggressive form of lung cancer.
Organon and Shanghai Henlius Biotech have announced that the European Medicines Agency (EMA) has validated a marketing authorisation application for HLX11, a biosimilar candidate referencing Roche’s ...
In advanced stages, people with ALS may lose the ability to stand, walk, independently get in and out of bed, use their hands ...
We found that most respondents had a positive perception of gene therapy, with 37% rating their perception as ‘very positive’ ...
Prime Global- The medical communications people. Prime Global is a group of six full-service medical communications agencies and specialist consultancies. We provide the world’s leading biotech, ...